Innovacyn Revenue

Medical Equipment Manufacturing • Rialto, California, United States • 21-50 Employees

Innovacyn revenue & valuation

Annual revenue	$17,000,000
Revenue per employee	$516,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$54,400,000
Total funding	No funding

Key Contacts at Innovacyn

Shannon Puckett

Director Of Clinical Operations

Spencer Hurst

Regional Sales Director - Eastern Us

Sonny Nolan

Director Of Sales

Geoff Hamby

Marketing Director - Vetericyn Animal Wellness At Innovacyn

Blair Burlingame

Director Of Philanthropy

Michelle Brainard

Director Of Ecommerce

Michael Nelson

Sr. Director Human Health, Western Region

Company overview

Headquarters	3546 N. Riverside Ave., Rialto, CA 92377, US
Phone number	+18663183116
Website	innovacyn.com
NAICS	3391
SIC	384
Keywords	Animal Wellness And Wound Care
Founded	2009
Employees	21-50
Socials

Innovacyn Email Formats

Innovacyn uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@innovacyn.com), used 73.9% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@innovacyn.com	73.9%
{first name}{last name}	johndoe@innovacyn.com	26.1%

About Innovacyn

Based in Rialto, Calif., Innovacyn Inc. is a privately held company that provides premier human and animal healthcare products based on advanced scientific research. Countless animals worldwide have safely benefited from the technology found in Innovacyn products. The company currently markets advanced healthcare to both the human and animal markets. Innovacyn promotes only those products it believes will truly revolutionize healthcare - products that create value for its trade partners and enrich lives for consumers. Innovacyn, Inc. is the company responsible for the brands Puracyn and Vetericyn. Puracyn and Vetericyn are rapidly growing brands that provide wound and skin care products for the human health market with Puracyn and animal health market with Vetericyn. Innovacyn products were formed for the purpose of providing premier health products to the animal market and human wound and skin care industry. Innovacyn revolutionizes healthcare with products that are effective, cause no harm to the skin and cause no harm to the environment. Innovacyn wants to be the company of choice for: Our team members and their families Our customers and their customers Our suppliers For more information about Innovacyn, visit www.innovacyn.com. All Innovacyn products are made in the U.S.A.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Manager

Entry

Director

Employees by Department

Innovacyn has 19 employees across 7 departments.

Departments

Number of employees

Funding Data

Innovacyn has never raised funding before.

Innovacyn Tech Stack

Discover the technologies and tools that power Innovacyn's digital infrastructure, from frameworks to analytics platforms.

Cloudflare Bot Management

Security

Animate.css

UI frameworks

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

Akismet

WordPress plugins

WordPress

Blogs

OceanWP

WordPress themes

Google Analytics

Analytics

Frequently asked questions

Innovacyn is located in Rialto, California, US.

You can reach Innovacyn at +18663183116.

Innovacyn generates an estimated annual revenue of $17,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Innovacyn has an estimated valuation of $54,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Innovacyn was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.

Innovacyn has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.